Fingerprint
Dive into the research topics of 'Phase II study of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone immunochemotherapy followed by yttrium-90- ibritumomab tiuxetan in untreated mantle-cell lymphoma: Eastern Cooperative Oncology Group study E1499'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically